The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Zoll Medical Corp.’s (NSDQ:ZOLL) LifeVest, the only wearable cardiac defibrillator on the market in the U.S., won a favorable policy decision from North Carolina’s Medicaid office.
The decision makes LifeVest reimbursable by North Carolina Medicaid for ischemic and non-ischemic patients who are at risk of sudden cardiac death and who aren’t good candidates for implanted devices.
MASSDEVICE ON CALL — President Barack Obama was handed a clean bill of health by White House doctors, who declared him "fit for duty."
The president has quit smoking, eats healthy and only drinks in moderation, the Wall Street Journal reported. Obama quit his nicotine habit over the last year, with a previous medical exam summary listing "nicotine replacement therapy" among his medications.
AtriCure Inc. (NSDQ:ATRC) could be poised for a buyout over the next year to 18 months, according to Canaccord Genuity analyst Jason Mills.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
A change to the way the LifeVest is reimbursed by Medicare would affect just 8 percent of Zoll Medical Corp.’s (NSDQ:ZOLL) total sales, CEO Richard Packer told a group of analysts Wednesday.
The top three medical device stories for Sept. 20, 2011.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
It’s been a rough end of the summer on The Street for Zoll Medical Corp. (NSDQ:ZOLL), which has seen its share price cut nearly in half over the past six weeks.
On August 1 shares of the Chelmsford, Mass.-based resuscitation company hit an all-time high of $70.82 during midday trading on Wall Street. Investors, buoyed by the company’s strong earnings results, helped push the stock price to new heights.
Analysts at Zacks Investment Research see sunnier days ahead for the medical device sector during the second half of 2011, despite lingering economic softness and ongoing pressure on the orthopedic market.
Estimating worldwide sales of roughly $300 billion this year, the researchers peg the U.S. market’s share at about $95 billion in 2010.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
Med-tech leaders came together for a meeting of the minds at MassDevice’s first Big 100 Regional Roundtable in Waltham, Mass., July 11. Four CEOs, each representing an interesting and important sector of the life science industry – the fascinating juncture between orthopedics and minimally invasive techniques, genomics and personalized medicine, the cutting edge of bio-interactive nanotech coatings and the mid-cap medical device world – shared their thoughts on the particular challenges facing their businesses and the life sciences industry as a whole.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with Massdevice +3.
